[HTML][HTML] Bradyarrhythmia after remdesivir administration in SARS-CoV-2: a review of literature and meta-analysis of observational studies in epidemiology
S Al-Jammali, R Al-Zakhari, N Sheets… - Cardiology …, 2022 - ncbi.nlm.nih.gov
Background The coronavirus disease 2019 (COVID-19) pandemic has required timely and
informed decisions about treatment recommendations for clinical practice. One such drug …
informed decisions about treatment recommendations for clinical practice. One such drug …
Identification of bradycardia following remdesivir administration through the US food and drug administration American college of medical toxicology COVID-19 toxic …
JM Devgun, R Zhang, J Brent, P Wax… - JAMA Network …, 2023 - jamanetwork.com
Importance The rapid spread and mortality associated with COVID-19 emphasized a need
for surveillance system development to identify adverse events (AEs) to emerging …
for surveillance system development to identify adverse events (AEs) to emerging …
Safety of anti-COVID treatments on the cardiovascular system
RS Sondh, M Vankad, P Saha, Y Bayatpoor - COVID-19's Consequences …, 2024 - Elsevier
Antivirals (remdesivir, Paxlovid, and molnupiravir) are used in severe COVID-19 cases with
specific indications and common side effects. Remdesivir may cause bradycardia, while …
specific indications and common side effects. Remdesivir may cause bradycardia, while …
[PDF][PDF] Major update 2: remdesivir for adults with COVID-19
Background: Remdesivir is being studied and used for treatment of coronavirus disease
2019 (COVID-19). Purpose: To update a previous review of remdesivir for adults with COVID …
2019 (COVID-19). Purpose: To update a previous review of remdesivir for adults with COVID …
Remdesivir-induced bradycardia in a 26-year-old patient with COVID-19: a case report
K Guziejko, J Talalaj, M Chorazy, M Groth… - Infection, 2022 - Springer
Purpose Remdesivir is the first line hospital treatment of the SARS-CoV-2 infection. Despite
its widespread use during COVID-19 pandemic, a limited number of data, also conflicting …
its widespread use during COVID-19 pandemic, a limited number of data, also conflicting …